ARCHIVES

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

This article is from The Cancer Letter archive.

Vol. 07 No. 33 | August 14, 1981

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996

Protein May Link Obesity To Cancer Aggressiveness

February 22, 2013

Program Announcements

August 3, 2001

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979

Sexual Function Affected By Stem Cell Transplant

September 28, 2007